Follow
Alfonso Duenas-Gonzalez
Alfonso Duenas-Gonzalez
Unit of Biomedical Research on Cancer, Instituto de Investigaciones Biomedicas UNAM, Instituto
Verified email at incan.edu.mx
Title
Cited by
Cited by
Year
Planning cancer control in Latin America and the Caribbean
PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ...
The lancet oncology 14 (5), 391-436, 2013
6152013
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin …
A Dueñas-González, JJ Zarbá, F Patel, JC Alcedo, S Beslija, L Casanova, ...
5222009
Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors
A Duenas-Gonzalez, M Candelaria, C Perez-Plascencia, ...
Cancer treatment reviews 34 (3), 206-222, 2008
4202008
Epigenetics of cervical cancer. An overview and therapeutic perspectives
A Dueñas-González, M Lizano, M Candelaria, L Cetina, C Arce, ...
Molecular cancer 4, 1-24, 2005
2982005
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M Candelaria, D Gallardo-Rincón, C Arce, L Cetina, JL Aguilar-Ponce, ...
Annals of Oncology 18 (9), 1529-1538, 2007
2932007
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy
B Segura-Pacheco, C Trejo-Becerril, E Perez-Cardenas, L Taja-Chayeb, ...
Clinical Cancer Research 9 (5), 1596-1603, 2003
2932003
OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line–specific manner
AD Gonzalez, M Kaya, W Shi, H Song, JR Testa, LZ Penn, J Filmus
The Journal of cell biology 141 (6), 1407-1414, 1998
2441998
The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug
M Juarez, A Schcolnik-Cabrera, A Dueñas-Gonzalez
American journal of cancer research 8 (2), 317, 2018
2272018
Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline
LT Chuang, S Temin, R Camacho, A Dueñas-Gonzalez, S Feldman, ...
Journal of global oncology 2 (5), 311-340, 2016
2192016
Ether a go-go potassium channels as human cervical cancer markers
LMB Farias, DB Ocana, L Diaz, F Larrea, E Avila-Chávez, A Cadena, ...
Cancer research 64 (19), 6996-7001, 2004
2042004
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative …
RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ...
Oncotarget 4 (4), 502, 2013
2012013
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
P Zambrano, B Segura-Pacheco, E Perez-Cardenas, L Cetina, ...
BMC cancer 5, 1-12, 2005
1992005
Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer
A Serrano-Olvera, A Dueñas-González, D Gallardo-Rincón, M Candelaria, ...
Cancer treatment reviews 32 (3), 180-190, 2006
1752006
A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin …
A Duenas-Gonzalez, C Lopez-Graniel, A Gonzalez-Enciso, L Cetina, ...
Annals of oncology 14 (8), 1278-1284, 2003
1732003
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
A Chavez-Blanco, B Segura-Pacheco, E Perez-Cardenas, L Taja-Chayeb, ...
Molecular cancer 4, 1-9, 2005
1702005
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer
C Arce, C Pérez-Plasencia, A González-Fierro, E de la Cruz-Hernández, ...
PloS one 1 (1), e98, 2006
1692006
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
A Chavez-Blanco, C Perez-Plasencia, E Perez-Cardenas, ...
Cancer cell international 6, 1-9, 2006
1632006
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
J Coronel, L Cetina, I Pacheco, C Trejo-Becerril, A González-Fierro, ...
Medical oncology 28, 540-546, 2011
1582011
Modern management of locally advanced cervical carcinoma
A Dueñas-Gonzalez, L Cetina, I Mariscal, J de la Garza
Cancer treatment reviews 29 (5), 389-399, 2003
1582003
Cancer progression mediated by horizontal gene transfer in an in vivo model
C Trejo-Becerril, E Pérez-Cárdenas, L Taja-Chayeb, P Anker, ...
PloS one 7 (12), e52754, 2012
1572012
The system can't perform the operation now. Try again later.
Articles 1–20